中文簡(jiǎn)介

Clinica Chimica Acta出版了臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)領(lǐng)域的原始研究通訊，定義為化學(xué)、生物化學(xué)、免疫化學(xué)、血液學(xué)的生化方面、毒理學(xué)和分子生物學(xué)在體液、細(xì)胞或組織中人類疾病研究中的應(yīng)用，其目標(biāo)是該雜志將出版新的信息，以更好地了解人類疾病的生物學(xué)機(jī)制、預(yù)防、診斷和患者管理。也歡迎有關(guān)應(yīng)用臨床特征的報(bào)告。有關(guān)正常代謝過(guò)程或正常細(xì)胞或體液成分的論文，如動(dòng)物實(shí)驗(yàn)或臨床研究報(bào)告，在其中被認(rèn)為與人類疾病有明確和直接的關(guān)系。還將考慮開(kāi)發(fā)和評(píng)估適用于臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)的新型分析方法，包括護(hù)理點(diǎn)測(cè)試，以及關(guān)于實(shí)驗(yàn)室管理和信息學(xué)的主題。除了最初的研究通訊外，該雜志還出版：（1）提供結(jié)論性結(jié)果或文件方法進(jìn)展的有限范圍的簡(jiǎn)短通訊報(bào)告；（2）致編輯的信，對(duì)發(fā)表在《臨床化學(xué)學(xué)報(bào)》上的論文發(fā)表評(píng)論-這些應(yīng)該少于400個(gè)字，可能包括1個(gè)插圖。R 1表；（3）邀請(qǐng)對(duì)醫(yī)學(xué)生物化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)的最新中心發(fā)展進(jìn)行評(píng)論；（4）涉及有趣或新穎臨床實(shí)驗(yàn)室數(shù)據(jù)的病例報(bào)告；（5）科學(xué)學(xué)會(huì)通訊；（6）會(huì)議公告。提交給Clinica Chimica Acta的打字稿以前不應(yīng)出版，也不應(yīng)考慮在其他地方出版。必須確認(rèn)所有指定作者同意提交。涉及人或動(dòng)物的調(diào)查必須注意相關(guān)的倫理批準(zhǔn)。如果作者對(duì)提議論文的范圍、格式或內(nèi)容有任何疑問(wèn)，請(qǐng)咨詢編輯委員會(huì)的任何成員。

投稿網(wǎng)址：http://ees.elsevier.com/cca/

英文簡(jiǎn)介

Clinica Chimica Acta publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids, cells or tissues The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are considered in they are clearly and directly relevant to human disease. Development and evaluation of novel analytical methologies where applicable to clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. In addition to original Research Communications the journal publishes: (1) Short Communications-concise reports of limited scope which offer conclusive results or document methodological advances; (2) Letters to the Editor, commenting on papers published in Clinica Chimica Acta - these should be less than 400 words and may include 1 illustration or 1 table; (3) Invited Critical Reviews of recent central developments in medical biochemistry and laboratory medicine; (4) case reports involving interesting or novel clinical laboratory data; (5) Newsletters of Scientific Societies; (6) Meeting announcements. Typescripts submitted to Clinica Chimica Acta should not have been published previously and should not be under consideration for publication elsewhere. The agreement of all named authors to the submission must be affirmed. Relevant ethical approval must be noted for investigations involving human or animal subjects. Authors are invited to consult any member of the Editorial Board, if in doubt about any aspect of scope, format or content of a proposed paper.